These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33766863)

  • 1. New problems erode confidence in AstraZeneca's vaccine.
    Vogel G; Kupferschmidt K
    Science; 2021 Mar; 371(6536):1294-1295. PubMed ID: 33766863
    [No Abstract]   [Full Text] [Related]  

  • 2. [Temporary suspension of AstraZeneca's vaccine; a reconstruction].
    Maas DPMSM; Kramers C; Smit HJCA; Middeldorp S; Helsloot I
    Ned Tijdschr Geneeskd; 2021 Apr; 165():. PubMed ID: 33914428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Audio Interview: A New Look at Covid-19 Vaccine Boosters.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Oct; 385(17):e72. PubMed ID: 34670050
    [No Abstract]   [Full Text] [Related]  

  • 4. The Johnson & Johnson Vaccine for COVID-19.
    Livingston EH; Malani PN; Creech CB
    JAMA; 2021 Apr; 325(15):1575. PubMed ID: 33646285
    [No Abstract]   [Full Text] [Related]  

  • 5. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 6. Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
    Rubin EJ; Baden LR; Walensky RP; Morrissey S
    N Engl J Med; 2021 Apr; 384(16):e73. PubMed ID: 33882211
    [No Abstract]   [Full Text] [Related]  

  • 7. How to redesign COVID vaccines so they protect against variants.
    Callaway E; Ledford H
    Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
    [No Abstract]   [Full Text] [Related]  

  • 8. Novavax offers first evidence that COVID vaccines protect people against variants.
    Callaway E; Mallapaty S
    Nature; 2021 Feb; 590(7844):17. PubMed ID: 33510489
    [No Abstract]   [Full Text] [Related]  

  • 9. Ensuring vaccine safety.
    Knipe DM; Levy O; Fitzgerald KA; Mühlberger E
    Science; 2020 Dec; 370(6522):1274-1275. PubMed ID: 33203781
    [No Abstract]   [Full Text] [Related]  

  • 10. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
    Russell RL; Pelka P; Mark BL
    Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UK has approved a COVID vaccine - here's what scientists now want to know.
    Ledford H; Cyranoski D; Van Noorden R
    Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887
    [No Abstract]   [Full Text] [Related]  

  • 12. BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
    Benenson S; Oster Y; Cohen MJ; Nir-Paz R
    N Engl J Med; 2021 May; 384(18):1775-1777. PubMed ID: 33755373
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
    Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
    Krause PR; Gruber MF
    N Engl J Med; 2020 Nov; 383(19):e107. PubMed ID: 33064383
    [No Abstract]   [Full Text] [Related]  

  • 15. Politicians must dial down the rhetoric over COVID vaccines.
    Nature; 2021 Mar; 591(7851):502. PubMed ID: 33758409
    [No Abstract]   [Full Text] [Related]  

  • 16. Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    Lee GM; Romero JR; Bell BP
    JAMA; 2020 Nov; 324(19):1937-1938. PubMed ID: 33064152
    [No Abstract]   [Full Text] [Related]  

  • 17. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 18. AstraZeneca's covid-19 (mis)adventure and the future of vaccine equity.
    Fortner R
    BMJ; 2022 Nov; 379():o2592. PubMed ID: 36368703
    [No Abstract]   [Full Text] [Related]  

  • 19. A promising inactivated whole-virion SARS-CoV-2 vaccine.
    Isakova-Sivak I; Rudenko L
    Lancet Infect Dis; 2021 Jan; 21(1):2-3. PubMed ID: 33069282
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.